Phase 4Completed
The Efficacy and Tolerability of Canagliflozin in Healthy Individual
The Efficacy and Tolerability of Canagliflozin in Healthy Individuals Comparing Dosing Protocols of Canagliflozin for Use as a Gerotherapeutic
- Sponsor
- AgelessRx (Industry)
- Enrolment
- 30 enrolled
- Conditions
- Healthy Aging
- Interventions
- Invokana Pill
- Ages
- adults, older adults
- Registry
- NCT06301529
From the registry
The primary objective is to measure the effects that canagliflozin intervention has on reducing average glucose in healthy individuals. The secondary objective is to assess the tolerability and side effects and urinary glucose excretion following the pulsatile dosing protocol.
Primary outcomes
- Change in blood glucose values after taking Canagliflozin